Literature DB >> 12630073

Is there a role for estrogens in the maintenance of men's health?

M Oettel1.   

Abstract

This paper gives an overview of our own studies and the literature on the biosynthesis and metabolism of estrogens in elderly men, the estrogen action in the male, and the clinical usefulness of estrogen therapy, including the phytoestrogens. Finally, the paper includes a short review of our knowledge of xenoestrogens and men's sexual health. A strong estrogen-deficient status is seen in male patients with mutations of the estrogen receptors or in cases of deviations of the aromatase gene. On the other hand, there are no clear age-dependent changes in estrogen secretion. But, in men with disorders of glucose metabolism and also of increased body mass index, the serum estrogen concentrations are significantly elevated. There are also strong positive correlations between serum estrogen levels and bone density, including prevalence of fractures and mood in men. New fields of interest are natural fatty esters of endogenous estrogens, e.g. lipoprotein-associated estrogens, and the role and clinical significance of tissue-specific, local estrogen biosynthesis (e.g. different promoters of the aromatase gene). Exogenous estrogen treatment is focused today on patients with normal testosterone and low levels of circulating estrogens documented on several occasions and with clinical symptoms of hormone deficiency; male-to-female transsexuals; and selected patients with prostate cancer. Some clinical studies show the benefits of estrogen treatment on some cardiovascular parameters and for treating selected signs of mental stress. An indirect estrogen replacement can occur if dehydroepiandrosterone is given orally to men. The clinical usefulness of dissociated estrogens, including non-feminizing estrogens and selective estrogen receptor modulators, is still an open question. The beneficial action of phytoestrogens in lowering the clinical symptoms of benign prostatic hyperplasia is well documented. Finally, the question about the definitive influence of so-called endocrine disruptors (xenoestrogens) on sexual functions in men is also discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12630073

Source DB:  PubMed          Journal:  Aging Male        ISSN: 1368-5538            Impact factor:   5.892


  10 in total

Review 1.  The endocrine pharmacology of testosterone therapy in men.

Authors:  Michael Oettel
Journal:  Naturwissenschaften       Date:  2004-01-28

2.  Polymorphisms of estrogen receptors and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China.

Authors:  Sue K Park; Gabriella Andreotti; Asif Rashid; Jinbo Chen; Philip S Rosenberg; Kai Yu; Jennifer Olsen; Yu-Tang Gao; Jie Deng; Lori C Sakoda; Mingdong Zhang; Ming-Chang Shen; Bing-Sheng Wang; Tian-Quan Han; Bai-He Zhang; Meredith Yeager; Stephen J Chanock; Ann W Hsing
Journal:  Carcinogenesis       Date:  2010-02-19       Impact factor: 4.944

Review 3.  Chemistry and structural biology of androgen receptor.

Authors:  Wenqing Gao; Casey E Bohl; James T Dalton
Journal:  Chem Rev       Date:  2005-09       Impact factor: 60.622

4.  Measuring fecal testosterone in females and fecal estrogens in males: comparison of RIA and LC/MS/MS methods for wild baboons (Papio cynocephalus).

Authors:  Laurence R Gesquiere; Toni E Ziegler; Patricia A Chen; Katherine A Epstein; Susan C Alberts; Jeanne Altmann
Journal:  Gen Comp Endocrinol       Date:  2014-05-04       Impact factor: 2.822

Review 5.  Endocrine milieu and erectile dysfunction: is oestradiol-testosterone imbalance, a risk factor in the elderly?

Authors:  Balasubramanian Srilatha; P Ganesan Adaikan
Journal:  Asian J Androl       Date:  2011-03-21       Impact factor: 3.285

Review 6.  Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs).

Authors:  Wenqing Gao; James T Dalton
Journal:  Drug Discov Today       Date:  2007-02-07       Impact factor: 7.851

Review 7.  Pharmacokinetics and pharmacodynamics of nonsteroidal androgen receptor ligands.

Authors:  Wenqing Gao; Juhyun Kim; James T Dalton
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

Review 8.  [Hormone therapy in the aging male. Estrogen, DHEA, melatonin, somatotropin].

Authors:  S Kliesch
Journal:  Urologe A       Date:  2004-09       Impact factor: 0.639

9.  Impact of the association between elevated oestradiol and low testosterone levels on erectile dysfunction severity.

Authors:  Ahmed I El-Sakka
Journal:  Asian J Androl       Date:  2013-05-06       Impact factor: 3.285

10.  [Intrinsic skin aging. A critical appraisal of the role of hormones].

Authors:  Ch C Zouboulis
Journal:  Hautarzt       Date:  2003-09       Impact factor: 0.751

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.